Revvity, Inc.
RVTYDiagnostics & Research
$157.00−5.30%As of Oct 30vs prior close
- Market cap
- $17.5B
- P/E (TTM)
- 75.1×
- P/E (FY1)
- 29.3×
- From 52W high
- −5.30%
- EPS (LTM)
- $2.09
- Revenue (LTM)
- $2.9B
- Net margin
- 8.16%
- Dividend yield
- 0.18%
Nomior Score
61
Steady ProfileTop 24% of the scored universe
Growth33
Quality62
Value51
Momentum90
Resilience52
Growth
+3.39%revenue a year over 9 fiscal years
YE16 $2.1BLTM $2.9B
Connections
Revenue to profitQ2 YE26
7% of revenue became net profit.
Who owns it
5funds